REDUCED INTENSITY CONDITIONING WITH FLUDARABINE, CYCLOPHOSPHAMIDE, AND HIGH DOSE RITUXAN FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR FOLLICULAR LYMPHOMA: A PHASE II MULTICENTER TRIAL FROM THE BLOOD AND MARROW TRANSPLANT NETWORK (BMT CTN)

Allogeneic hematopoietic cell transplantation (alloHCT) can induce long term remissions in chemosensitive relapsed follicular lymphoma (FL). The BMT CTN conducted a multicenter phase 2 trial to examine the efficacy of alloHCT using reduced intensity conditioning (RIC) with rituximab (RTX) in multipl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Blood Marrow Transplant
Autors principals: Laport, Ginna G, Wu, Juan, Logan, Brent, Bachanova, Veronika, Hosing, Chitra, Fenske, Timothy, Longo, Walter, Devine, Steven M, Nademanee, Auayporn, Gersten, Iris, Horowitz, Mary, Lazarus, Hillard M, Riches, Marcie L
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4949103/
https://ncbi.nlm.nih.gov/pubmed/27118571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.04.014
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars